Development of a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This pilot study will evaluate whether an intervention aimed at hospitalized patients with advanced lung and gastrointestinal cancers can help facilitate goals-of-care (GOC) communication with their oncologists after discharge. While GOC communication is a recommended component of routine oncology care, many patients with solid cancers do not have the opportunity to talk with their oncologist about their goals and end-of-life preferences. Prior research has shown that a systematic method of prompting GOC communication with at-risk patients would address a key barrier to timely GOC communication and ensure that patients receive care that is in line with their personal preferences. This trial will enroll 80 participants, who will be randomized 1:1 to either an intervention or a control group. Participants in the intervention group will complete a short survey regarding their goals, preferences, and disease understanding. Survey responses will be shared with each participant's outpatient oncology team. Oncologists will subsequently receive a nudge in the electronic medical record reminding them of key survey responses and encouraging them to discuss them at the patient's first clinic visit after hospital discharge. The primary feasibility outcome is intervention completion rate and the primary clinical outcome is GOC documentation within 30 days of discharge in the intervention group compared to the control group.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Unplanned admission to the HUP Solid Oncology service;

• Underlying diagnosis of advanced lung or GI cancer, defined as metastatic or locally advanced disease;

• Anticipated discharge within the next 72h; and

• Primary oncologist is based at HUP; or

• Family member/caregiver of a patient meeting the above 4 criteria.

Locations
United States
Pennsylvania
Hospital of the University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Lauren Reed-Guy, MD
lauren.reed-guy@pennmedicine.upenn.edu
215-535-9927
Time Frame
Start Date: 2025-07-21
Estimated Completion Date: 2026-05
Participants
Target number of participants: 80
Treatments
Experimental: Intervention
Participants in the intervention arm will complete a survey prior to hospital discharge. Their responses will be shared with each participant's outpatient oncology team.
No_intervention: Control
Related Therapeutic Areas
Sponsors
Collaborators: Conquer Cancer Foundation
Leads: Abramson Cancer Center at Penn Medicine

This content was sourced from clinicaltrials.gov